生物
毒力
肺炎克雷伯菌
微生物学
生物膜
寄生虫学
肠杆菌科
病毒学
克雷伯菌感染
抗生素耐药性
细菌
抗性(生态学)
后天抵抗
克雷伯菌
细菌蛋白
致病性
抗药性
病菌
多位点序列分型
作者
Min Huang,Sheng-Ping Xiao,Qing-Hua Zeng,Hua-Ming Guo,Yating Liu,Dan-Dan Wei,Xiu-Hua Kang
标识
DOI:10.1186/s12866-025-04654-5
摘要
BACKGROUND: Antibiotic-resistant Klebsiella pneumoniae (KP) poses a serious global public health threat. However, research on the resistance mechanisms and accompanying phenotypic changes in carbapenem-resistant hypervirulent KP (CR-hvKP) under antibiotic treatment remains limited. This study aims to investigate the resistance mechanisms of CR-hvKP to ceftazidime-avibactam (CAZ-AVI) and its concomitant phenotypic shifts, employing an in vitro induction assay. METHODS: Six ceftazidime-avibactam (CAZ-AVI)-susceptible CR-hvKP clinical isolates were subjected to in-vitro resistance induction. We used pulsed-field gel electrophoresis, whole-genome sequencing, biofilm formation, a Galleria mellonella infection model, and in-vitro competitive growth assays to characterize the virulence and adaptive changes of the isolates. RESULTS: CAZ-AVI-resistant CR-hvKP demonstrated enhanced biofilm formation capacity, but the G. mellonella infection model indicated a decrease in virulence of the drug-resistant strain. While resistant strains exhibited diminished competitive fitness in vitro, growth curves did not differ significantly. Genomic characterization identified both resistant and susceptible isolates as ST11, with resistant isolates exhibiting an expanded resistance gene profile, primarily involving KPC-2 variants. All strains carried typical virulence determinants, including iroE (a glycosidase gene within the salmochelin siderophore system), iucABCD (the aerobactin biosynthesis operon), and iutA (the gene encoding the outer membrane receptor for ferric-aerobactin). CONCLUSIONS: CAZ-AVI resistance acquisition in CR-hvKP primarily occurs through KPC-2 mutations. Strains harboring such mutations exhibit enhanced biofilm formation capacity but attenuated virulence and competitiveness. Research into these adaptive changes will facilitate the development of improved clinical strategies for the treatment and control of carbapenem-resistant hypervirulent Klebsiella pneumoniae.
科研通智能强力驱动
Strongly Powered by AbleSci AI